3,4-(Methylenedioxy)aniline CAS 14268-66-7: A Key Pharmaceutical Intermediate for Advanced Synthesis
Unlock potent therapeutic potential with this crucial building block in pharmaceutical and organic synthesis.
Get a Quote & SampleProduct Core Value
3,4-(Methylenedioxy)aniline
This compound is a vital pharmaceutical intermediate, serving as a versatile building block for the synthesis of complex molecules. Its unique methylenedioxy group influences electronic properties and lipophilicity, making it invaluable in drug discovery and development, particularly for agents targeting neurodegenerative diseases and cancer. The aniline moiety provides a reactive site for diverse chemical transformations.
- Explore the synthesis pathways for 3,4-(Methylenedioxy)aniline to optimize reaction yields.
- Utilize this key pharmaceutical intermediate for the creation of novel anticancer agents.
- Leverage the properties of methylenedioxy aniline derivatives in drug-receptor interactions.
- Discover the application of CAS 14268-66-7 in the development of inhibitors for enzymes like MAO and AChE.
Advantages Provided by the Product
Advanced Synthesis Applications
This compound is instrumental in advanced organic synthesis, enabling the construction of intricate heterocyclic compounds essential for modern therapeutics.
Therapeutic Potential
Its derivatives show promise in treating neurodegenerative diseases and inhibiting cancer cell growth, highlighting its significance in drug discovery.
Chemical Versatility
The reactive aniline group allows for extensive functionalization, creating diverse compound libraries for comprehensive biological screening.
Key Applications
Pharmaceutical Intermediate
Crucial for synthesizing APIs and advanced drug candidates, supporting the development of new treatments.
Organic Synthesis Building Block
A versatile starting material for creating complex organic molecules and heterocyclic scaffolds.
Drug Discovery Research
Facilitates the design of novel therapeutic agents for conditions like cancer and neurodegenerative diseases.
Chemical Research and Development
A key reagent for exploring new synthetic pathways and chemical transformations in R&D settings.